EGFR and non-small cell lung carcinoma: Additionally, EGFR testing is recommended for rarer EGFR variants (e.g., EGFR Ex20ins variants; EGFR p.Ser768Ile, p.Leu861Gln and/or p.Gly719X) in eligible patients with metastatic NSCLC [13].